Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides

The p53 tumor suppressor serves as a major barrier against malignant transformation. Over 50% of tumors inactivate p53 by point mutations in its DNA binding domain. Most mutations destabilize p53 protein folding, causing its partial denaturation at physiological temperature. Thus a high proportion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tal, Perry, Eizenberger, Shay, Cohen, Elad, Goldfinger, Naomi, Pietrokovski, Shmuel, Oren, Moshe, Rotter, Varda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914250/
https://www.ncbi.nlm.nih.gov/pubmed/26943582
http://dx.doi.org/10.18632/oncotarget.7857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914250/
https://www.ncbi.nlm.nih.gov/pubmed/26943582
http://dx.doi.org/10.18632/oncotarget.7857

Ejemplares similares